Cell News and Research

RSS

Researchers discover elusive nanoscale movements of ribosomes at work

Researchers at the University of California, Berkeley, have for the first time captured elusive nanoscale movements of ribosomes at work, shedding light on how these cellular factories take in genetic instructions and amino acids to churn out proteins.

24 Aug 2009

Scientists to discuss effective treatments for serious diseases at Functional Genomics/Chemical Biology conference

A cure for cystic fibrosis, HIV-fighting 'Trojan horses', new pharmaceuticals from the ocean. Chemical biologists use new and innovative approaches to discover medications of the future. On 24 August, some of the field's most prominent researchers will attend an international conference in Gothenburg, Sweden.

24 Aug 2009

MarrowXpress System used for isolation and retrieval of bone marrow-derived adult stem cells

Celling Technologies collaborated with innovative cell processing expert, ThermoGenesis Corp., to deliver the most sophisticated point of care cell separation device on the market. The innovative MarrowXpress(TM) (MXP(TM)) System defines a new standard for isolation and retrieval of bone marrow-derived adult stem cells.

21 Aug 2009

FDA approves Epocal's new glucose test on the epoc Blood Analysis System

Epocal, Inc., a leading edge provider of point of care technology, announced today that it has received U.S. Food and Drug Administration (FDA) clearance to market its new glucose test on the epoc Blood Analysis System.

21 Aug 2009

Lonza submits non-binding proposal to buy all of outstanding restricted voting shares of Patheon

The Special Committee of Independent Directors of Patheon Inc. (TSX:PTI) and Lonza Group AG (SIX:LONN) announced today that Lonza, one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries, has submitted a non-binding proposal to acquire all of the outstanding Restricted Voting Shares of Patheon at a price of US$3.55 per Restricted Voting Share.

21 Aug 2009

CEL-SCI to raise $4.4 million by selling 9.7 million units to institutional investors

CEL-SCI Corporation. (NYSE Amex: CVM), a biotechnology company entering a late stage oncology trial and focused on infectious disease, today announced that it has entered into a definitive agreement with several institutional investors to sell 9.7 million units, with each unit consisting of one of the Company's common shares and 0.50 warrants to purchase one share of common stock, for gross proceeds of approximately $4.4 million, before deducting placement agent fees and estimated offering expenses, in a "registered direct" offering.

21 Aug 2009

Clinical grade stem cells to be manufactured by Stemedica as it awaits FDA approval of an IND to commence clinical trials

Stemedica Cell Technologies, Inc. USA, a leader in adult stem cell research and manufacturing, has requested a pre-Investigational New Drug (IND) meeting with the U.S. Food and Drug Administration ("FDA") to discuss a proposed IND to use Stemedica's proprietary line of allogeneic mesenchymal bone marrow cells (adult human) as a treatment for ischemic stroke.

21 Aug 2009

Cannabis chemicals stop prostate cancer growth

Active chemicals in cannabis have been shown to halt prostate cancer cell growth according to research published in the British Journal of Cancer today.

21 Aug 2009

Care Support Of America CEO offers advice on caregiving to aging relatives

Summer has its own serious issues for seniors living at home, but a little bit of planning by family caregivers can go a long way should a weather emergency occur. Summer emergencies include not only major disasters like hurricanes and wildfires, but also heat emergencies and storms that knock out electricity and access to services," says Dr. Dan Tobin, CEO of Care Support of America, a national family caregiving service.

21 Aug 2009

Ends of protein templates useful for arresting growth of cancerous cells

The tail ends of cellular protein templates, regions often thought relatively inconsequential, may actually play a role in preventing normal cells from becoming cancerous. The finding from scientists at Whitehead Institute for Biomedical research is reported in the August 20 edition of Cell.

21 Aug 2009

Nixle's free technology provides critical real-time alerts on H1N1 Flu

Nixle, a secure community information tool, which has been rapidly adopted by over 1,800 law enforcement agencies across the country, is now offering its free technology to hospitals and schools to provide critical real-time alerts on the H1N1 Flu.

21 Aug 2009

Research study discovers lethal effects of tetracycline and chloramphenicol against certain bacterial strains

By studying the intricate mechanisms at work in protein production, a Princeton-led team has discovered why certain kinds of antibiotics are so effective. In doing so, they also have discovered how one protein protects against cell death, shedding light on a natural cancer-fighting process.

21 Aug 2009

Researchers develop new ways for splitting dangerous pair of cancer proteins

A research team led by U of T Mississauga scientists has developed a new way to split up a dangerous pair of cancer proteins, a finding that could ultimately lead to chemotherapy that is more effective and has fewer side effects.

21 Aug 2009

TCT Featured Clinical Trials to be presented on September 24 in San Francisco

A series of Featured Clinical Trials will be presented at Transcatheter Cardiovascular Therapeutics (TCT), in addition to late-breaking clinical trials. These featured clinical trials represent groundbreaking research and will yield data and insight that will further the field of interventional cardiology.

21 Aug 2009

More evidence that genes increase a smokers' risk of lung cancer

Cancer Research UK funded scientists have confirmed that inherited changes in certain regions of the genome can increase a smokers' risk of developing lung cancer lung cancer, and determine the type of lung cancer that develops. Their results were published in this week's edition of the journal Cancer Research*.

21 Aug 2009

New discovery on cellular fusion

Success in soccer sometimes comes with "bending it like Beckham." Success in cellular fusion - as occurs at the moment of conception and when nerve cells exchange neurotransmitters - requires that a membrane be bent before the merging process can begin, University of Wisconsin-Madison researchers have shown.

20 Aug 2009

IBISS research group's project aims to examine Ribavirin role in promoting the survival of transplanted stem cells

Hard to Treat Diseases (HTDS.PK) Dr. Sanja Pekovic, Chief Project Scientist, Chief Strategy Officer Slavica BioChem reported that IBISS research group from Serbia has begun preliminary experiments within a project aimed at Promoting stem cell graft survival in the model of traumatic brain injury in rats.

20 Aug 2009

Poniard Pharmaceuticals may sell up to $60 million of its registered common stock to finance its picoplatin clinical development and commercialization programs

...

20 Aug 2009

Advaxis awarded $210,000 for development of a dual antigen vaccine

Advaxis, Incorporated (OTCBB: ADXS), the live, attenuated Listeria monocytogenes (Lm) vaccine company, has been awarded a $210,000 grant from the US National Institute of Health (NIH) to develop a single bioengineered Lm vaccine to deliver two different antigen-adjuvant proteins.

20 Aug 2009

Shape-changing in proteins opens new avenue for drug discovery

Computational biologists at the University of Pittsburgh School of Medicine have shown that proteins have an intrinsic ability to change shape, and this is required for their biological activity. This shape-changing also allows the small molecules that are attracted to a given protein to select the structure that permits the best binding. That premise could help in drug discovery and in designing compounds that will have the most impact on protein function to better treat a host of diseases.

20 Aug 2009

Cell News and Research

Researchers discover elusive nanoscale movements of ribosomes at work

Scientists to discuss effective treatments for serious diseases at Functional Genomics/Chemical Biology conference

MarrowXpress System used for isolation and retrieval of bone marrow-derived adult stem cells

FDA approves Epocal's new glucose test on the epoc Blood Analysis System

Lonza submits non-binding proposal to buy all of outstanding restricted voting shares of Patheon

CEL-SCI to raise $4.4 million by selling 9.7 million units to institutional investors

Clinical grade stem cells to be manufactured by Stemedica as it awaits FDA approval of an IND to commence clinical trials

Cannabis chemicals stop prostate cancer growth

Care Support Of America CEO offers advice on caregiving to aging relatives

Ends of protein templates useful for arresting growth of cancerous cells

Nixle's free technology provides critical real-time alerts on H1N1 Flu

Research study discovers lethal effects of tetracycline and chloramphenicol against certain bacterial strains

Researchers develop new ways for splitting dangerous pair of cancer proteins

TCT Featured Clinical Trials to be presented on September 24 in San Francisco

More evidence that genes increase a smokers' risk of lung cancer

New discovery on cellular fusion

IBISS research group's project aims to examine Ribavirin role in promoting the survival of transplanted stem cells

Poniard Pharmaceuticals may sell up to $60 million of its registered common stock to finance its picoplatin clinical development and commercialization programs

Advaxis awarded $210,000 for development of a dual antigen vaccine

Shape-changing in proteins opens new avenue for drug discovery

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest Life Science News